MARÍA ISABEL
TEJADA MÍNGUEZ
Ikertzailea 2019-(e)ra arte
Instituto de Salud Carlos III
Madrid, EspañaInstituto de Salud Carlos III -ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2020
-
Molecular characterization of Spanish patients with MECP2 duplication syndrome
Clinical Genetics, Vol. 97, Núm. 4, pp. 610-620
2010
-
BRCA1 5272-1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin
Clinical Genetics, Vol. 77, Núm. 1, pp. 60-69